DE60024450D1 - Modulierung der angiogenese durch verwendung von anti-angiogenischen angiotensin-7 und dafür kodierende polynukleotiden zur behandlung von tumoren - Google Patents
Modulierung der angiogenese durch verwendung von anti-angiogenischen angiotensin-7 und dafür kodierende polynukleotiden zur behandlung von tumorenInfo
- Publication number
- DE60024450D1 DE60024450D1 DE60024450T DE60024450T DE60024450D1 DE 60024450 D1 DE60024450 D1 DE 60024450D1 DE 60024450 T DE60024450 T DE 60024450T DE 60024450 T DE60024450 T DE 60024450T DE 60024450 D1 DE60024450 D1 DE 60024450D1
- Authority
- DE
- Germany
- Prior art keywords
- angiotensin
- angiogenic
- angiogenesis
- polynucleotides
- tumors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 title 1
- 230000001772 anti-angiogenic effect Effects 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99113502 | 1999-07-02 | ||
| EP99113502 | 1999-07-02 | ||
| PCT/US2000/018170 WO2001002434A1 (en) | 1999-07-02 | 2000-06-30 | Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60024450D1 true DE60024450D1 (de) | 2006-01-05 |
| DE60024450T2 DE60024450T2 (de) | 2006-08-03 |
Family
ID=8238583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60024450T Expired - Fee Related DE60024450T2 (de) | 1999-07-02 | 2000-06-30 | Modulierung der angiogenese durch verwendung von anti-angiogenischen angiotensin-7 und dafür kodierende polynukleotiden zur behandlung von tumoren |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1192181B1 (de) |
| AU (1) | AU6340200A (de) |
| CA (1) | CA2377788A1 (de) |
| DE (1) | DE60024450T2 (de) |
| ES (1) | ES2252032T3 (de) |
| WO (1) | WO2001002434A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057435A (en) * | 1997-09-19 | 2000-05-02 | Genentech, Inc. | Tie ligand homologues |
| AU1598599A (en) * | 1997-11-20 | 1999-06-15 | Genetix Pharmaceuticals, Inc. | Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases |
| WO1999062925A1 (en) * | 1998-06-02 | 1999-12-09 | Eli Lilly And Company | Angiopoietin related gene sequence scarface 1 |
| AU6417799A (en) * | 1998-10-09 | 2000-05-01 | Incyte Pharmaceuticals, Inc. | Matrix-remodeling genes |
-
2000
- 2000-06-30 DE DE60024450T patent/DE60024450T2/de not_active Expired - Fee Related
- 2000-06-30 ES ES00950276T patent/ES2252032T3/es not_active Expired - Lifetime
- 2000-06-30 AU AU63402/00A patent/AU6340200A/en not_active Abandoned
- 2000-06-30 EP EP00950276A patent/EP1192181B1/de not_active Expired - Lifetime
- 2000-06-30 WO PCT/US2000/018170 patent/WO2001002434A1/en active IP Right Grant
- 2000-06-30 CA CA002377788A patent/CA2377788A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001002434A1 (en) | 2001-01-11 |
| DE60024450T2 (de) | 2006-08-03 |
| AU6340200A (en) | 2001-01-22 |
| CA2377788A1 (en) | 2001-01-11 |
| ES2252032T3 (es) | 2006-05-16 |
| EP1192181B1 (de) | 2005-11-30 |
| EP1192181A1 (de) | 2002-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| ATE241986T1 (de) | Verwendung von chinazolin verbindungen zur behandlung von polyzystischer nierenkrankheit | |
| DE50212701D1 (de) | Bestrahlungsanordnung zur behandlung von akne und aknenarben | |
| NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
| ATE414512T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| DE60030554D1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| DE69922914D1 (de) | Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux | |
| DE69831222D1 (de) | Verbindungen zur immundiagnose von prostatakrebs und deren verwendung | |
| DK2412368T3 (da) | Sammensætning til behandling af ar | |
| DE60133921D1 (de) | Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie | |
| DE69814656D1 (de) | Neue verbesserte formulierung zur behandlung der osteoporose | |
| DE69925865D1 (de) | 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen | |
| ATE239509T1 (de) | Konjugate zur behandlung von prostatakrebs | |
| DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
| EP1443820A4 (de) | Zusammensetzung und verfahren zur behandlung der transplantat-wirt-reaktion | |
| DE60220043D1 (de) | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen | |
| DE60214355D1 (de) | Exemestan zur behandlung von hormonabhängigen störungen | |
| DE60130365D1 (de) | Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen. | |
| DE50006142D1 (de) | Verfahren zur thermischen Behandlung von mehlförmigen Rohmaterialien | |
| DE60026644D1 (de) | Verwendung von Ferulasäure zur Behandlung von Bluthochdruck | |
| DE60001255D1 (de) | Zusammensetzung zur Behandlung von Polyesterfaser | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE60217653D1 (de) | Verwendung von melatonin zur behandlung der mit konzentrationsschwäche einhergehenden hyperaktivität | |
| DE60024450D1 (de) | Modulierung der angiogenese durch verwendung von anti-angiogenischen angiotensin-7 und dafür kodierende polynukleotiden zur behandlung von tumoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |